Boston Partners Innoviva, Inc. Transaction History

Boston Partners

$80.6 Billion
Q3 2024

A detailed history of Boston Partners transactions in Innoviva, Inc. stock. As of the latest transaction made, Boston Partners holds 341,344 shares of INVA stock, worth $6.09 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

341,344

Previous 532,754 35.93%

Holding current value

$6.09 Million

Previous $8.74 Million 24.61%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$16.33 - $20.04 $3.13 Million - $3.84 Million	-191,410 Reduced 35.93%	341,344 $6.59 Million
Q2 2024 Aug 13, 2024	BUY	$14.4 - $16.4 $2.03 Million - $2.32 Million	141,298 Added 36.1%	532,754 $8.74 Million
Q1 2024 May 13, 2024	BUY	$14.56 - $16.78 $2.71 Million - $3.12 Million	185,784 Added 90.33%	391,456 $5.97 Million
Q4 2023 Feb 07, 2024	SELL	$12.32 - $16.27 $2.31 Million - $3.06 Million	-187,798 Reduced 47.73%	205,672 $3.3 Million
Q3 2023 Nov 07, 2023	BUY	$12.37 - $13.89 $449,191 - $504,387	36,313 Added 10.17%	393,470 $5.11 Million
Q2 2023 Aug 10, 2023	BUY	$11.39 - $13.72 $2.64 Million - $3.18 Million	231,481 Added 184.19%	357,157 $4.55 Million
Q1 2023 May 09, 2023	BUY	$10.73 - $13.6 $67,191 - $85,163	6,262 Added 5.24%	125,676 $1.41 Million
Q4 2022 Feb 07, 2023	BUY	$11.8 - $13.78 $351,758 - $410,781	29,810 Added 33.27%	119,414 $1.58 Million
Q3 2022 Nov 09, 2022	BUY	$11.61 - $15.22 $181,255 - $237,614	15,612 Added 21.1%	89,604 $1.04 Million
Q2 2022 Aug 10, 2022	BUY	$14.32 - $19.88 $859,586 - $1.19 Million	60,027 Added 429.84%	73,992 $1.09 Million
Q1 2022 May 10, 2022	BUY	$15.39 - $20.25 $214,921 - $282,791	13,965 New	13,965 $270,000
Q4 2021 Feb 04, 2022	SELL	$15.91 - $18.72 $638,388 - $751,140	-40,125 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$13.06 - $17.24 $524,032 - $691,754	40,125 New	40,125 $670,000

Others Institutions Holding INVA

# of Institutions

227

Shares Held

78.9M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.24B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.

Account